GR3025186T3 - The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids - Google Patents

The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids

Info

Publication number
GR3025186T3
GR3025186T3 GR970402821T GR970402821T GR3025186T3 GR 3025186 T3 GR3025186 T3 GR 3025186T3 GR 970402821 T GR970402821 T GR 970402821T GR 970402821 T GR970402821 T GR 970402821T GR 3025186 T3 GR3025186 T3 GR 3025186T3
Authority
GR
Greece
Prior art keywords
preparing
pharmaceutical composition
disorders related
cns disorders
composition against
Prior art date
Application number
GR970402821T
Other languages
English (en)
Inventor
Leif Helth Jensen
Jorgen Drejer
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of GR3025186T3 publication Critical patent/GR3025186T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
GR970402821T 1990-04-13 1997-10-29 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids GR3025186T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50928490A 1990-04-13 1990-04-13

Publications (1)

Publication Number Publication Date
GR3025186T3 true GR3025186T3 (en) 1998-02-27

Family

ID=24026006

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402821T GR3025186T3 (en) 1990-04-13 1997-10-29 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids

Country Status (12)

Country Link
EP (1) EP0451626B1 (el)
JP (1) JP3015129B2 (el)
AT (1) ATE157873T1 (el)
CA (1) CA2040242A1 (el)
DE (1) DE69127572T2 (el)
DK (1) DK0451626T3 (el)
ES (1) ES2108017T3 (el)
FI (1) FI911784A (el)
GR (1) GR3025186T3 (el)
IE (1) IE910939A1 (el)
NO (1) NO911449L (el)
PT (1) PT97365B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317018A (en) * 1992-06-09 1994-05-31 Armin Walser Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
CA2138533C (en) * 1992-07-24 2009-04-14 Gary S. Lynch Drugs that enhance synaptic responses mediated by ampa receptors
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
GB2346883B (en) * 1996-09-02 2001-02-14 Lilly Industries Ltd GluR5 receptor binding assay
KR102362725B1 (ko) * 2018-10-22 2022-02-15 (주)엘엑스하우시스 창호 시공용 낙하방지망 조립체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine

Also Published As

Publication number Publication date
EP0451626A2 (en) 1991-10-16
IE910939A1 (en) 1991-10-23
PT97365B (pt) 1998-08-31
DK0451626T3 (da) 1998-04-20
NO911449D0 (no) 1991-04-12
DE69127572T2 (de) 1998-01-22
NO911449L (no) 1991-10-14
PT97365A (pt) 1992-01-31
ES2108017T3 (es) 1997-12-16
ATE157873T1 (de) 1997-09-15
JPH04224516A (ja) 1992-08-13
EP0451626A3 (en) 1992-10-07
JP3015129B2 (ja) 2000-03-06
EP0451626B1 (en) 1997-09-10
DE69127572D1 (de) 1997-10-16
CA2040242A1 (en) 1991-10-14
FI911784A (fi) 1991-10-14
FI911784A0 (fi) 1991-04-12

Similar Documents

Publication Publication Date Title
IL95568A0 (en) N-substituted-4-pyrimidinamines and pyrimidinidiamines,process for their preparation and pharmaceutical compositions containing them
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
PH31123A (en) Benzimidazole compounds.
HU9300898D0 (en) Non-aromatic heterocyclic compounds containing condensed nitrogenb
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
IL106670A0 (en) Substituted benzylamino nitrogen containing non-aromatic heterocycles
HUT62889A (en) Process for producing benzoisothiazole and benzoisoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NZ221543A (en) 4-aminoquinoline derivatives and pharmaceutical compositions containing such
GR3025186T3 (en) The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
PT85869A (en) Process for preparing amino acid derivative anti-convulsant
IL104657A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems